ABOUT US

CH Life Science Private Limited, established on February 18, 2021, is a Bangalore-based pharmaceutical company focused on innovative diagnostic technologies and affordable medicine. The company’s vision is to be a global leader in providing high-quality, cost-effective pharmaceutical products to improve the quality of life. CH Life Science operates across research, development, production, and marketing of in vitro diagnostics and therapeutic solutions.

Mission and Vision

Mission : CH Life Science Private Limited is dedicated to improving global healthcare by providing high-quality, affordable pharmaceutical products. The company aims to become a recognized leader in domestic and international markets, driving innovation in diagnostics and therapeutics while enhancing the quality of life for society through accessible and cost-effective solutions. Future Vision : CH Life Science aims to grow its portfolio by acquiring new products, enhancing its therapeutic areas, and addressing social issues through innovation and collaboration. The company strives to become a global pharmaceutical leader while maintaining a strong domestic presence

Company Profile

Our company CH Life Science Private Limited was founded in 2021, to continuously take on the innovative diagnostic technology for each life. We will contribute to people’s health and medical development using our innovative diagnostic technology to meet consistent challenges. We will continuously strive to supply our test agents in consideration of our company’s significance of existence for the health and happiness of individuals living every day and a secure society filled with laughter

Research and Development

Antigen and Antibody-Production Technologies
Innovative Diagnostic Technologies
Support of New Drug Discovery
Research and development of reagents
Clinical performance study and pharmaceutical licensing application
Production system
Quality management
Product examples
CH Life Science Private Limited operates all processes required for manufacturing in vitro diagnostics
products, from R&D to clinical performance study, to regulatory authorization application, to
manufacturing and marketing. This system builds a close and trusted partnership with TOP physicians
and achieves speedy commercialization.

Quality policy

CH Life Science Private Limited shall maintain and continually improve the effectiveness of the quality
management system and deliver customer-oriented quality.
CH Life Science Private Limited shall listen to the information from customers and carefully and
promptly make responses.
CH Life Science Private Limited shall give first priority to the compliance with the laws and regulatory
requirements and deliver safe and secure products and services.

Directors

1. Ravindra Kumar: He is having vast Medical Marketing experience of overall 25 years in Pharmaceutical industry holding a PHD DEGREE (MEDICAL) His global values and behaviors provide with strong foundations, and has have the flexibility to do what is right for our customers.

2. Ayda Hossein Poor: Holding Doctorate (Pharma) she is managing a Bangalore Based Company “HP PRIDE EXIM” ESTD 2022, with an annual turnover of INR One Crore in India along with the UAE Office operations holding a Green Card (UAE). She is a part of (CH LIFE SCIENCE PVT. LTD) Her overall roles & responsibilities includes Medicines Research, Market survey, Selection of rights formulation and dosage of medicines, decision making related to packaging and marketing name and getting approval from the respective authority department

3. Sara Hossein Poor: Sister of Ayda Hossein Poor Holding Doctorate (Pharma) she is Partner in Bangalore Based Company “HP PRIDE EXIM” ESTD 2022, with an annual turnover of INR One Crore in India along with the UAE Office operations holding a Green Card (UAE). She is a part of (CH LIFE SCIENCE PVT. LTD) handling other departments of (Manufacturing/production, Marketing and budget management). She is extremely efficient in coordinating, and executing marketing campaigns, preparing reports on market research, competition, and customer insights, and collaborating effectively with team members on various projects.

4. Rakesh Chandra: Dr. Rakesh Chandra is a Business entrepreneur, Director of “India Education Foundation: Established in the year 2000, the India Education Foundation (IEF) Education Consultants. Managing Partner of RK OVERSEAS Private Limited for Worldwide Admissions in Top Universities Globally. Having corporate tie ups with 600 plus universities across the globe. He leads his programming organization through thought-to-execution leadership, delivering results and creating high-performing result oriented successful teams. He is Trust Chairman to Organizations like “Shri Shrishti Charitable Trust” & Dhanyabad Foundation, also running schools. For CH Life Science Private Limited, embracing the combination of global strengths and the uniquely Indian ways of working has been key to starting the local company culture. As the Director of a fast-growing, international mid-size pharmaceutical company, he is very much responsible to continuously build and form a company that is competitive, resilient and innovative, allowing to successfully navigating in a complex and constantly changing environment.
5. Newly appointed Director Mr. Jyothi Krishna Murthy, who is having Company in Hyderabad by the name of “Smarts Choice Educational Services (SCES)” providing support for Students admissions for Top Universities of India & RK OVERSEAS Private Limited Managing Partner of RK OVERSEAS Private Limited for Worldwide Admissions in Top Universities . Having corporate tie ups with 600 plus universities across the globe providing support for Students admissions for Top Universities (UK, USA, Canada, Australia, New Zealand and many more) with a 1000 plus admissions provided worldwide annually. The company started with only four members in the organization when ESTD 202and so far has developed in the last three years by leaps & bounds. To expand our business, we’re partnering on promising products that complement our in-house portfolio and will help us achieve long-term growth. Our strategy involves acquiring new products and product candidates, and companies that will drive our portfolio in key therapeutic areas

Our Present Team Strength:

Total – 33 Employee’s
Medical Representative: 24
Field Manager: 6
Regional Sales Manager: 2
Zonal Sales Manager: 1

Financial Strength
We are very much eligible to fulfill all prospects on behalf of the committed order from effective
operating profitability, efficient capital structure management an appropriate pay out of returns
to owners through dividends and appreciation of ownership value.
Support expected from Tie Up Manufacturing Company
 Respond to the order demand fluctuations as & when arises, complete support of
documentation & overall consignment procedure requirement’s (Observance of laws,
ordinances and social norms)
 Emphasis on quality, delivery dates and stable supply
 Packing as per statutory input output norms.
 Payment Terms: Advance 30% at the time of order & balance after the dispatch of goods
 Master Plan (Layout Blueprint